• CCG-1423: A RhoA Inhibitor Workflow

  2026-08-24

  CCG-1423 provides a pathway-focused way to interrogate MRTF-A nuclear import, proliferation, invasion, and apoptosis without treating it as a direct ROCK1 kinase blocker. This guide translates that distinction into practical cancer research and exploratory barrier or viral-entry assays, with dosing, controls, and troubleshooting built around interpretable readouts.

• MK 0893 and the Extra-Helical GCGR Site

  2026-08-23

  The reference study resolved a 2.5 Å structure of human glucagon receptor bound to MK 0893, revealing an unexpected allosteric pocket between transmembrane helices 6 and 7. Structural analysis and mutagenesis showed how this site can stabilize an inactive receptor conformation and provided a framework for structure-based design of class B GPCR antagonists.

• LY294002: Reliable PI3K Assay Workflows

  2026-08-22

  Learn how LY294002 (SKU A8250) can reduce variability in cell viability, proliferation, apoptosis, and autophagy studies through disciplined dosing, solvent controls, and pathway-level validation. This scenario-driven guide connects biochemical potency with practical assay design and responsible data interpretation.

• EZ Cap Cy5 Firefly Luciferase mRNA in Context

  2026-08-21

  EZ Cap Cy5 Firefly Luciferase mRNA combines fluorescent delivery tracking with functional luciferase expression. This guide explains how protein-corona effects can cause uptake and translation to diverge, enabling more rigorous interpretation of mRNA delivery and transfection experiments.

• Caffeic Acid Phenethyl Ester in Neurodegeneration

  2026-08-21

  Caffeic Acid Phenethyl Ester (CAPE) provides a practical way to isolate NF-κB-dependent inflammation from Fyn–Stat3 signaling in neurodegeneration models. This guide connects zebrafish dopaminergic-neuron assays with CAPE anti-angiogenesis research, emphasizing solvent control, pathway-specific readouts, and reproducible dosing.

• Patient-Derived Gastric Cancer Assembloids

  2026-08-20

  Shapira-Netanelov and colleagues developed patient-derived gastric cancer assembloids that combine tumor organoids with matched stromal subpopulations from the same tumor. The model reproduced tumor–stroma-associated transcriptional features and revealed that stromal composition can alter therapeutic sensitivity, supporting more physiologically relevant drug-response studies.

• S Tag Peptide: Practical Fusion Tag Workflow

  2026-08-20

  S Tag Peptide supports recombinant protein detection, antibody-based purification, and protein solubility improvement when encoded as an N- or C-terminal fusion. It should not be treated as an independently active RNase fragment, and its free-peptide form is unsuitable for ethanol-based workflows or long-term storage in solution.

• PD98059 (A1663) for MEK/ERK Assays

  2026-08-19

  Learn how PD98059 (SKU A1663) can clarify MAPK/ERK-dependent changes in cell viability, proliferation, apoptosis, and lipid metabolism. This scenario-based guide covers mechanism, controls, stock preparation, interpretation, and practical supplier selection.

• TG003 Cdc2-like kinase inhibitor workflow

  2026-08-19

  TG003 enables reversible control of Clk-dependent splicing for exon-skipping, splice site selection, and cancer-cell experiments. This workflow pairs practical dosing and readouts with the reference study’s CLK2–BRCA1 resistance mechanism while clearly separating validated findings from testable hypotheses.

• Aztreonam as a Resistance-Phenotyping Control

  2026-08-18

  Aztreonam offers a focused way to study antibiotic activity against Gram-negative aerobic bacteria while separating phenotype, genotype, and transmission. This article connects Aztreonam assay design with multidimensional carbapenemase research and defines practical interpretation limits.

• Ruxolitinib: Designing Interpretable JAK Assays

  2026-08-18

  Ruxolitinib (INCB018424) is a selective JAK1/2 inhibitor for connecting kinase perturbation with immune and progenitor-cell phenotypes. This guide focuses on experimental design, spectral profiling, controls, and causal interpretation in myelofibrosis research and combination immunology studies.

• SAR131675: A Translational Lens on VEGFR-3

  2026-08-17

  A thought-leadership guide to using SAR131675 as a mechanistic VEGFR-3 inhibitor for dissecting lymphangiogenesis, angiogenesis, and tumor biology while accounting for assay context, formulation, selectivity, and translational limitations.

• Angiotensin I: A Smarter Assay-Design Framework

  2026-08-16

  Angiotensin I is more than an inactive renin-angiotensin system intermediate: it is a controllable substrate for separating enzymatic conversion from downstream cardiovascular signaling. This article combines peptide mechanism, assay architecture, and lessons from spectral-interference research to improve interpretation in cardiovascular disease mechanisms and drug screening.

• ARCA EGFP mRNA (5-moUTP) Workflow Guide

  2026-08-15

  ARCA EGFP mRNA (5-moUTP) provides a direct, fluorescence-based readout for transfection and protein expression in mammalian cells. Its oriented ARCA cap, 5-moUTP chemistry, and optimized poly(A) tail support reproducible reporter signal while offering a practical framework for controlling storage, handling, and assay variability.

• Dynasore Workflow for Endocytosis Research

  2026-08-15

  Build a controlled, reversible workflow for testing dynamin-dependent uptake with Dynasore, from DMSO stock preparation to quantitative nanoparticle and cargo internalization assays. The approach translates recent corneal nanoparticle findings into practical controls for endocytosis research, synaptic vesicle studies, signal transduction pathway study, and hypothesis-driven cancer research.

451 records 7/31 page Previous Next First page 上5页 678910 下5页 Last page